Domperidone stimulates prolactin secretion potentially via dopaminergic mechanism by inhibiting the prolactin inhibiting factor (PIF) at the level of hypothalamus, consequently fostering uninhibited prolactin release i.e., hyperprolactinemia. This evidence concerns the gene PRL and hyperprolactinemia.